The report “Radiation Dose Management Market by Offering (Product: Integrated, Standalone; Services), Modality (CT, Mammography, NM), Revenue Model (Pay-Per Procedure, Annual Purchase), Application (Oncology, Cardiology, Ortho), End User – Global Forecast to 2028″, is projected to reach USD 654 million by 2028 from USD 343 million in 2023, at a CAGR of 13.8%.
Browse 275 market data Tables and 52 Figures spread through 293 Pages and in-depth TOC on “Radiation Dose Management Market by Offering (Product: Integrated, Standalone; Services), Modality (CT, Mammography, NM), Revenue Model (Pay-Per Procedure, Annual Purchase), Application (Oncology, Cardiology, Ortho), End User – Global Forecast to 2028”
View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/radiation-dose-management-market-82326344.html
The growth in the radiation dose management market is primarily driven by a surge in the utilization of medical imaging modalities, propelled by a rising incidence of chronic diseases. As healthcare demands increase, the prevalence of diagnostic and interventional procedures involving ionizing radiation, such as X-rays and CT scans, is on the rise. Additionally, there is a growing awareness regarding radiation dose management practices among healthcare professionals and patients, further emphasizing the need for comprehensive solutions. The convergence of these factors, including the use of medical imaging, increasing awareness of radiation risks, increasing prevalence of chronic diseases, and the growth in radiology equipment installations, collectively contribute to the growth of the radiation dose management market in the forecast period.
Standalone solutions accounted for the larger share of the radiation dose management solution market in 2022
On the basis of product & service, the radiation dose management market is segmented into radiation dose management solutions and services. The radiation dose management solution is further sub-segmented into standalone and integrated. In 2022, the standalone solution segment held the largest share in the market. Due to stringent regulations and standards governing radiation exposure in healthcare, there is an increasing emphasis on compliance. As standalone and integrated solutions offer features that enable healthcare providers to adhere to regulatory requirements efficiently. The emphasis on enhancing overall patient outcomes serves as a driving force for the widespread adoption of radiation dose management solutions.
By application, the oncology segment accounted for the largest market share in 2022
Based on application, the radiation dose management market is segmented into oncology, cardiology, orthopaedic applications, dental, and other application. The oncology segment accounted for the largest market share in 2019. The rising prevalence of cancer, are driving the demand for oncology treatments, including radiation therapy. There is growing emphasis on personalized medicine in oncology, as treatments are tailored to individual patients based on their unique characteristics and the specific nature of the cancer. This personalized approach necessitates precise and individualized radiation dose planning and management, driving the demand for advanced solutions within the oncology segment.
Hospitals are the largest end users of the radiation dose management market
Based on end users, the radiation dose management market is segmented into hospitals and healthcare system, ambulatory surgery centres, diagnostic and imaging centres, and other end users. The hospitals segment accounted for the largest market share in 2022. Hospitals conduct a substantial number of medical imaging procedures, such as X-rays, CT scans, and fluoroscopy, for diagnostic purposes. The increased frequency of these procedures contributes to a greater need for radiation dose management to ensure patient safety and regulatory compliance. Moreover, the rising patient population, growing awareness about the benefits of early disease diagnosis, technological advancements in imaging modalities are the major factors responsible for the high demand for radiation dose management solutions in hospitals.
North America dominates the global radiation dose management market
The radiation dose management market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2022, North America accounted for the largest share of the radiation dose management market. The region’s leadership can be attributed to its significant healthcare IT expenditure, stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, and the presence of stringent regulatory requirements regarding patient safety.
Key Players
Prominent players in the radiation dose management market include Bayer AG (Germany), GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), FUJIFILM Holdings Corporation (Japan), Canon Inc. (Japan), PACSHealth, LLC (US), Sectra AB (Sweden), Bracco Imaging S.p.A. (Italy), Qaelum N.V. (Belgium), Agfa Healthcare (Belgium), Novarad Corporation (US), Medic Vision (US), Volpara Solutions Inc. (US), Guerbet (France), Medsquare (France), and INFINITT Healthcare Co. Ltd. (South Korea).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
